Tomasz Zabinski

687 total citations
9 papers, 377 citations indexed

About

Tomasz Zabinski is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Tomasz Zabinski has authored 9 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Tomasz Zabinski's work include IL-33, ST2, and ILC Pathways (4 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Tomasz Zabinski is often cited by papers focused on IL-33, ST2, and ILC Pathways (4 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Tomasz Zabinski collaborates with scholars based in United Kingdom, United States and Japan. Tomasz Zabinski's co-authors include Ana C. Parente‐Pereira, John Maher, Lynsey M. Whilding, David M. Davies, Leena Halim, Benjamin Draper, Roseanna M. Petrovic, Sadaf Ghaem‐Maghami, Shelia M. Violette and John F. Marshall and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Frontiers in Immunology.

In The Last Decade

Tomasz Zabinski

8 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Zabinski United Kingdom 6 279 166 101 84 84 9 377
Guoxiu Du China 6 397 1.4× 233 1.4× 84 0.8× 131 1.6× 72 0.9× 6 516
Roseanna M. Petrovic United Kingdom 5 238 0.9× 104 0.6× 86 0.9× 76 0.9× 65 0.8× 8 282
Petra Schuberth Switzerland 7 289 1.0× 140 0.8× 70 0.7× 185 2.2× 81 1.0× 11 446
Cody E. Cotner United States 4 464 1.7× 183 1.1× 127 1.3× 136 1.6× 89 1.1× 10 537
Benjamin Draper United Kingdom 4 326 1.2× 147 0.9× 133 1.3× 102 1.2× 80 1.0× 7 394
Leena Halim United Kingdom 5 246 0.9× 200 1.2× 81 0.8× 77 0.9× 74 0.9× 7 360
Won‐Ju Kim South Korea 10 180 0.6× 203 1.2× 63 0.6× 152 1.8× 53 0.6× 23 414
Annika De Sousa Linhares Austria 7 270 1.0× 212 1.3× 42 0.4× 95 1.1× 23 0.3× 11 400
Sascha Haubner Germany 9 393 1.4× 263 1.6× 50 0.5× 207 2.5× 97 1.2× 16 614
Robin Davies United States 4 519 1.9× 214 1.3× 192 1.9× 103 1.2× 145 1.7× 8 570

Countries citing papers authored by Tomasz Zabinski

Since Specialization
Citations

This map shows the geographic impact of Tomasz Zabinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Zabinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Zabinski more than expected).

Fields of papers citing papers by Tomasz Zabinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Zabinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Zabinski. The network helps show where Tomasz Zabinski may publish in the future.

Co-authorship network of co-authors of Tomasz Zabinski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Zabinski. A scholar is included among the top collaborators of Tomasz Zabinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Zabinski. Tomasz Zabinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Masdeu, M., Tomasz Zabinski, Janakan Sam Narean, et al.. (2024). HEMATOPOIETIC STEM CELL GENE THERAPY AS A NOVEL THERAPEUTIC APPROACH FOR SEVERE CROHN’S DISEASE ASSOCIATED WITH NOD2-DEFICIENCY. Inflammatory Bowel Diseases. 30(Supplement_1). S42–S42.
2.
Masdeu, M., Tomasz Zabinski, Janakan Sam Narean, et al.. (2024). HEMATOPOIETIC STEM CELL GENE THERAPY AS A NOVEL THERAPEUTIC APPROACH FOR SEVERE CROHN’S DISEASE ASSOCIATED WITH NOD2-DEFICIENCY. Gastroenterology. 166(3). S58–S58. 1 indexed citations
3.
Lo, Jonathan W., Tomasz Zabinski, Nick Powell, et al.. (2023). CD90 is not constitutively expressed in functional innate lymphoid cells. Frontiers in Immunology. 14. 1113735–1113735. 4 indexed citations
4.
Jowett, Geraldine M., Emily Read, Luke B. Roberts, et al.. (2022). Organoids capture tissue-specific innate lymphoid cell development in mice and humans. Cell Reports. 40(9). 111281–111281. 24 indexed citations
5.
Roberts, Luke B., Katrin Meissl, Jonathan W. Lo, et al.. (2021). Sustained Post-Developmental T-Bet Expression Is Critical for the Maintenance of Type One Innate Lymphoid Cells In Vivo. Frontiers in Immunology. 12. 760198–760198. 14 indexed citations
6.
Whilding, Lynsey M., Leena Halim, Benjamin Draper, et al.. (2019). CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. Cancers. 11(5). 674–674. 166 indexed citations
7.
Petrovic, Roseanna M., Daniela Achkova, Tomasz Zabinski, et al.. (2017). CAR T-cell immunotherapy of MET-expressing malignant mesothelioma. OncoImmunology. 6(12). e1363137–e1363137. 52 indexed citations
8.
Whilding, Lynsey M., Ana C. Parente‐Pereira, Tomasz Zabinski, et al.. (2017). Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Molecular Therapy. 25(1). 259–273. 69 indexed citations
9.
Parente‐Pereira, Ana C., Hilary Shmeeda, Lynsey M. Whilding, et al.. (2014). Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid. The Journal of Immunology. 193(11). 5557–5566. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026